SCIEQ2
Regenerative Therapy
ELSEVIER
Regenerative Therapy is an academic journal published by ELSEVIER. Identifiers: ISSN 2352-3204, eISSN 2352-3204. Indexed in SCIE. Metrics: JIF 3.5. Subject areas: BIOMEDICAL, CELL & TISSUE ENGINEERING, ENGINEERING, ENGINEERING, BIOMEDICAL. tlooto lists 1,303 papers from this journal.
CiteScore
-
Scopus citation metric
SJR
-
SCImago rank
SNIP
-
Source normalized impact
Percentage rank
-
JIF percentile rank
Journal profile
- ISSN
- 2352-3204
- eISSN
- 2352-3204
- Abbreviation
- REGEN THER
- Publisher
- ELSEVIER
- Country
- -
Web of Science categories
SCIEBIOMEDICAL, CELL & TISSUE ENGINEERING, ENGINEERING
Scopus ASJC categories
No ASJC category data available.
Keywords
Cell & Tissue Engineering | Engineering, Biomedical
Papers in this journal
Recent papers
- Design and initial evaluation of a certified committee model for review of in vivo gene therapy and related technologies, together with ex vivo gene therapy, under the act on the safety of regenerative medicine
2026
- Low-frequency electromagnetic fields ameliorate testosterone-induced androgenetic alopecia in mice through LncRNA H19/miR-214-5p/β-catenin signal pathway
2026
- Harnessing Platelet-derived factors to reactivate Nucleus Pulposus cells in Intervertebral Disc Regeneration
2026
- Extracellular vesicles derived from adipose-derived mesenchymal stem/stromal cells prevent synovial inflammation and attenuate cartilage degeneration in rodent osteoarthritis
2026 · 1 citations
- Abnormal circ-CDK8 expression affects periodontitis development by regulating let-7b-5p/MAP4K3 signaling
2026
Most cited papers
- Periodontal regeneration with autologous periodontal ligament-derived cell sheets – A safety and efficacy study in ten patients
2018 · 177 citations
- Applications of 3D printed bone tissue engineering scaffolds in the stem cell field
2021 · 161 citations
- iPS cell-based therapy for Parkinson's disease: A Kyoto trial
2020 · 147 citations
- Advances in regenerative therapy: A review of the literature and future directions
2020 · 145 citations
- First-in-human clinical trial of transplantation of iPSC-derived NS/PCs in subacute complete spinal cord injury: Study protocol
2021 · 129 citations